Search

Search Results

##search.searchResults.foundPlural##

Increased plasma lipocalin-2 levels correlate with disease severity and may be a marker of acute inflammatory response in patients with psoriasis

Chuyen Thi Hong Nguyen, Oanh Phan Tram Nguyen

21-11-2022

https://doi.org/10.4081/dr.2022.9469

1167

PDF: 465

HTML: 29
Prevalence and association of renal disorders in Saudi adult patients with psoriasis and psoriatic arthritis: a tertiary-center retrospective cross-sectional study

Mishari T. Alrubaiaan, Abdullah D. Alhobabi, Raghad M. Alharthi, Saad A. Alsulaiman, Abdullah N. Altasan, Ibrahim M. Momen, Mohammad Almohideb

02-01-2025

https://doi.org/10.4081/dr.2025.10083

472

PDF: 218

HTML: 4
Treatment satisfaction among patients with psoriasis in Saudi Arabia

Mahdi Aldhafiri, Rahaf Almutairi, Reem Albejais, Asma Almubark, Hussain Alwesaibie, Mohammed Albesher, Manayer Almustihi

15-04-2024

https://doi.org/10.4081/dr.2024.9967

831

PDF: 440

HTML: 18
Increased serum interleukin-31 levels correlate with pruritus in psoriatic patients: a cross-sectional study in Vietnam

Chuyen Thi Hong Nguyen, Liem Viet Quoc Tran

27-11-2024

https://doi.org/10.4081/dr.2024.10090

519

PDF: 250

HTML: 10
Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus

Martina Burlando, Elena Campione, Aldo Cuccia, Giovanna Malara, Luigi Naldi, Francesca Prignano, Leonardo Zichichi

29-12-2022

https://doi.org/10.4081/dr.2023.9613

1640

PDF: 450

HTML: 72
Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

Andrea Cortese, Luigi Gargiulo, Luciano Ibba, Giovanni Fiorillo, Francesco Toso, Carlo Alberto Vignoli, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

19-05-2023

https://doi.org/10.4081/dr.2023.9692

918

PDF: 470

HTML: 17
A characterization of the expression of 14-3-3 isoforms in psoriasis, basal cell carcinoma, atopic dermatitis and contact dermatitis

Line Raaby, Kristian Otkjær, Maria Luise Salvskov-Iversen, Claus Johansen, Lars Iversen

e14

14-10-2010

https://doi.org/10.4081/dr.2010.e14

3968

PDF: 756

HTML: 320
Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs

Viviana Lora, Dario Graceffa, Monia Di Prete, Carlo Cota

11-11-2024

https://doi.org/10.4081/dr.2024.10140

727

PDF: 372

SUPPLEMENTARY MATERIAL: 75

HTML: 4
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as inflammatory markers in psoriasis: a case-control study

Hao Trong Nguyen, Long Dinh Hoang Vo, Nguyen Nhat Pham

14-07-2022

https://doi.org/10.4081/dr.2022.9516

1443

PDF: 593

HTML: 17
Natural language processing of online support group postings reveals patients’ perspectives on strategies for managing psoriasis

Karan Rajalingam, Phillip M. Johansen, Nicole J. Levin, Jerry Qi, Oge Marques

11-09-2023

https://doi.org/10.4081/dr.2023.9824

780

PDF: 441

HTML: 25
Erythrodermic psoriasis improved by tildrakizumab

Giampaolo Trevisan, Lerica Germi, Luigi Naldi

23-11-2022

https://doi.org/10.4081/dr.2022.9448

1001

PDF: 543

HTML: 18
Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience

Gioele Ghezzi, Luciano Ibba, Luigi Gargiulo, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

12-11-2024

https://doi.org/10.4081/dr.2024.10080

933

PDF: 463

HTML: 10
A study on tumor necrosis factor-α single nucleotide polymorphisms and psoriasis vulgaris in Vietnam

Vinh Ngo Minh, Thiên Phúc Lý, Hao Nguyen Trong, Chuong Nguyen Hoang

12-04-2024

https://doi.org/10.4081/dr.2024.9899

855

PDF: 490

HTML: 20
Bacterial colonization of psoriasis plaques. Is it relevant?

Eva Marcus, Diana Demmler, Andreas Rudolph, Matthias Fischer

e14

05-08-2011

https://doi.org/10.4081/dr.2011.e14

1547

PDF: 704

HTML: 621
Infliximab-induced intertriginous psoriasis in patient with Crohn's desease

Federica Mola, Alberico Motolese

e40

03-10-2011

https://doi.org/10.4081/dr.2011.e40

1172

PDF: 549

HTML: 1070
Erythrodermic psoriasis treated with apremilast

John Arcilla, Daniel Joe, Johnathan Kim, Yohanan Kim, VuAnh N. Truong, Navin Jaipaul

19-09-2016

https://doi.org/10.4081/dr.2016.6599

1957

PDF: 880

HTML: 597
Late reaction to ustekinumab infusion

Marina Resener Morais, Luana Pizarro Meneghello, Carina Flores de Oliveira, André Vicente Esteves Carvalho

e2

09-09-2013

https://doi.org/10.4081/dr.2013.e2

3832

PDF: 613

HTML: 259
Real-world treatment patterns, patient-reported outcomes, and effectiveness of flexible-dosing etanercept in patients with plaque psoriasis in Greece

Dimitris Rigopoulos, Aikaterini Patsatsi, Christina Antoniou, Dimitrios Sotiriadis, Angeliki Roussaki-Schulze, Nadia Boubouchairopoulou, Ioannis Skiadas, Vasillios Tsekouras, Ana Cristina Hernandez Daly

21-11-2022

https://doi.org/10.4081/dr.2022.9265

1412

PDF: 372

HTML: 21
Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

Nicoletta Bernardini, Nevena Skroza, Giovanni Rossi, Alessandra Mambrin, Ersilia Tolino, Federica Marraffa, Martina Caviglia, Antonio Di Guardo, Salvatore Volpe, Ilaria Proietti, Concetta Potenza

21-11-2022

https://doi.org/10.4081/dr.2022.9447

1207

PDF: 352

HTML: 39
Guselkumab for the treatment of severe plaque psoriasis in a schizophrenia patient

Nicoletta Bernardini, Nevena Skroza, Elisabeth Prevete, Federica Marraffa, Ilaria Proietti, Ersilia Tolino, Alessandra Mambrin, Giovanni Rossi, Salvatore Volpe, Giuseppe Bersani, Concetta Potenza

23-11-2022

https://doi.org/10.4081/dr.2022.9476

1262

PDF: 420

HTML: 23
Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

Pablo Santa María, Fernando Valenzuela, Claudia Morales, Raul De la Fuente, Roberto Cullen

11-10-2017

https://doi.org/10.4081/dr.2017.7079

1232

PDF: 592

HTML: 138
A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks

Luciano Ibba, Luigi Gargiulo, Giulia Pavia, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

06-06-2023

https://doi.org/10.4081/dr.2023.9722

673

PDF: 389

HTML: 14
A case of squamous cell carcinoma arising in a giant porokeratosis previously diagnosed as psoriasis

Lorry Aitkens, Joel Byrne, Charay Jennings-Dover, Kathryn Anne Potter

29-12-2022

https://doi.org/10.4081/dr.2023.9634

835

PDF: 391

HTML: 110
Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

Alba Guglielmo, Maria Ludovica Deotto , Luigi Naldi , Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina, Andrea Sechi

13-09-2023

https://doi.org/10.4081/dr.2023.9839

2288

PDF: 857

HTML: 26
Narrowband UVB-induced lichen planus pemphigoides

Wai Man Mandy Chan, Joyce Siong See Lee, Colin Seng Thiam Theng, Sze Hon Chua, Hazel Hwee Boon Oon

e43

25-10-2011

https://doi.org/10.4081/dr.2011.e43

2627

PDF: 763

HTML: 1345

1 - 25 of 41 items 1 2 > >>

Search

Search Results

Increased plasma lipocalin-2 levels correlate with disease severity and may be a marker of acute inflammatory response in patients with psoriasis

Prevalence and association of renal disorders in Saudi adult patients with psoriasis and psoriatic arthritis: a tertiary-center retrospective cross-sectional study

Treatment satisfaction among patients with psoriasis in Saudi Arabia

Increased serum interleukin-31 levels correlate with pruritus in psoriatic patients: a cross-sectional study in Vietnam

Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus

Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

A characterization of the expression of 14-3-3 isoforms in psoriasis, basal cell carcinoma, atopic dermatitis and contact dermatitis

Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as inflammatory markers in psoriasis: a case-control study

Natural language processing of online support group postings reveals patients’ perspectives on strategies for managing psoriasis

Erythrodermic psoriasis improved by tildrakizumab

Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience

A study on tumor necrosis factor-α single nucleotide polymorphisms and psoriasis vulgaris in Vietnam

Bacterial colonization of psoriasis plaques. Is it relevant?

Infliximab-induced intertriginous psoriasis in patient with Crohn's desease

Erythrodermic psoriasis treated with apremilast

Late reaction to ustekinumab infusion

Real-world treatment patterns, patient-reported outcomes, and effectiveness of flexible-dosing etanercept in patients with plaque psoriasis in Greece

Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

Guselkumab for the treatment of severe plaque psoriasis in a schizophrenia patient

Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks

A case of squamous cell carcinoma arising in a giant porokeratosis previously diagnosed as psoriasis

Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

Narrowband UVB-induced lichen planus pemphigoides

authors

reviewers

indexing

dermatopathology

Keywords